Cargando…
Multi-targeted therapy resistance via drug-induced secretome fucosylation
Cancer secretome is a reservoir for aberrant glycosylation. How therapies alter this post- translational cancer hallmark and the consequences thereof remain elusive. Here, we show that an elevated secretome fucosylation is a pan-cancer signature of both response and resistance to multiple targeted t...
Autores principales: | Aldonza, Mark Borris D, Cha, Junghwa, Yong, Insung, Ku, Jayoung, Sinitcyn, Pavel, Lee, Dabin, Cho, Ryeong-Eun, Delos Reyes, Roben D, Kim, Dongwook, Kim, Soyeon, Kang, Minjeong, Ku, Yongsuk, Park, Geonho, Sung, Hye-Jin, Ryu, Han Suk, Cho, Sukki, Kim, Tae Min, Kim, Pilnam, Cho, Je-Yoel, Kim, Yoosik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089660/ https://www.ncbi.nlm.nih.gov/pubmed/36961502 http://dx.doi.org/10.7554/eLife.75191 |
Ejemplares similares
-
Chemotherapy confers a conserved secondary tolerance to EGFR inhibition via AXL-mediated signaling bypass
por: Aldonza, Mark Borris D., et al.
Publicado: (2021) -
Paraoxonase-1 (PON1) induces metastatic potential and apoptosis escape via its antioxidative function in lung cancer cells
por: Aldonza, Mark Borris D., et al.
Publicado: (2017) -
Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters
por: Shin, Sol-Bi, et al.
Publicado: (2021) -
Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms
por: Aldonza, Mark Borris D., et al.
Publicado: (2020) -
Strategies of Mesenchymal Invasion of Patient-derived Brain Tumors: Microenvironmental Adaptation
por: Cha, Junghwa, et al.
Publicado: (2016)